Mounjaro in India : A Breakthrough in Diabetes and Obesity Treatment: SPER Market Research
Eli Lilly’s Mounjaro (Tirzepatide) has emerged as a game-changer in tackling two major health challenges—type 2 diabetes and obesity. By mimicking the effects of two crucial hormones, GLP-1 and GIP,…